Details for New Drug Application (NDA): 215022
✉ Email this page to a colleague
The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Summary for 215022
Tradename: | SUCCINYLCHOLINE CHLORIDE |
Applicant: | Sagent Pharms Inc |
Ingredient: | succinylcholine chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 215022
Physiological Effect | Neuromuscular Depolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 215022
Suppliers and Packaging for NDA: 215022
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 215022 | ANDA | Sagent Pharmaceuticals | 25021-677 | 25021-677-10 | 25 VIAL in 1 CARTON (25021-677-10) / 10 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
Approval Date: | Mar 29, 2021 | TE: | AP | RLD: | No |
Complete Access Available with Subscription